Healthcare & Pharmaceutical

Region

Research Reports in Healthcare & Pharmaceutical


Safety Lancet Market Size, Share & Trends Analysis By Type (Auto-Retractable Lancet, Pressure-Activated Lancet, Twist-Top Safety Lancet, Low-Flow Safety Lancet), By Gauge (21G, 23G, 25G, 28G, 30G), By End-Use (Hospital, Homecare, Pharmacy, Clinics), By Application (Blood Glucose Monitoring, Blood Collection, Neonatal Screening), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

The global safety lancet market is growing driven by auto-retractable lancet adoption, blood glucose lancet demand, diabetic lancet devices, pain-free lancet technology, pressure-activated lancet, disposable safety lancet, twist-top safety lancet, and hospital safety lancet across diabetes management, blood collection, and neonatal screening applications.

Read More »

July 2026


Laboratory Proficiency Testing Market Size, Share & Trends Analysis By Type (Chemical Proficiency Testing, Microbiological Proficiency Testing, Physical Proficiency Testing), By End-Use (Clinical Laboratories, Environmental Testing Labs, Food Testing Labs, Pharmaceutical Labs, Water Testing Labs), By Provider (Proficiency Testing Provider, Reference Material Provider), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

The global laboratory proficiency testing market is growing driven by proficiency testing providers, external quality assessment (EQA), ISO 17043 compliance, interlaboratory comparison programs, environmental proficiency testing, food testing proficiency, microbiological proficiency testing, and chemical proficiency testing for laboratory accreditation and regulatory compliance.

Read More »

July 2026


Overactive Bladder Treatment Market Size, Share & Trends Analysis By Treatment Type (Anticholinergic Drugs, Beta-3 Adrenergic Agonists, Botulinum Toxin Therapy, Sacral Neuromodulation, Percutaneous Tibial Nerve Stimulation, Behavioral Therapy), By Drug Class (Oxybutynin, Solifenacin, Mirabegron, Vibegron, Darifenacin, Fesoterodine), By End-Use (Hospital, Specialty Clinic, Home Care), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

The global overactive bladder treatment market is expanding driven by OAB medication market growth, beta-3 adrenergic agonists including mirabegron OAB and vibegron treatment, botulinum toxin OAB treatment, sacral neuromodulation therapy, percutaneous tibial nerve stimulation, and non-invasive OAB treatment for bladder control management.

Read More »

July 2026


IoT Healthcare Market Size, Share & Trends Analysis By Component (Connected Healthcare Devices, Healthcare IoT Platforms, Smart Medical Sensors, Software, Services), By Application (Remote Patient Monitoring, Continuous Patient Monitoring, Healthcare Asset Tracking, IoT-Enabled Diagnostics, Smart Insulin Delivery Systems), By End-Use (Hospitals, Clinics, Home Healthcare, Long-Term Care), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

The global IoT healthcare market is growing driven by connected healthcare devices, remote patient monitoring, wearable medical devices, smart hospital solutions, healthcare IoT platforms, AI-powered health monitoring, smart medical sensors, and healthcare predictive analytics across hospitals, home healthcare, and long-term care settings.

Read More »

July 2026


Clinical Trials Market Size, Share & Forecast, By Phase (Phase I, II, III, IV), By Study Design (Interventional, Observational, Expanded Access), By Therapeutic Area (Oncology, Cardiovascular, Infectious Diseases), By Service Provider (CROs, In-House), By Region, 2025–2032

Decentralized trials, real-world evidence, and adaptive study designs are reshaping the clinical trial landscape. Pharma and biotech companies are increasingly outsourcing to CROs for speed, compliance, and access to diverse patient pools.

Read More »

March 2026


Neurodegenerative Disease Therapeutics Market Size, By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s), By Drug Class (Cholinesterase Inhibitors, Dopamine Agonists, Antidepressants, NMDA Antagonists), By Route of Administration, By Distribution Channel, By Region, 2025–2032

With aging populations and rising prevalence of Alzheimer’s and Parkinson’s, demand for effective therapeutics is rising. Investments in disease-modifying treatments, early diagnosis tools, and biotech-led innovation are transforming care models.

Read More »

June 2025


Biopharmaceutical Contract Manufacturing Market Size, Share & Trends, By Service Type (Mammalian, Microbial, Fill-Finish, Cell Banking), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins), By Client Type (Big Pharma, Biotech Startups), By Region, 2025–2032

Biologics outsourcing is booming due to the surge in mAb, vaccine, and gene therapy production. Pharma companies are leveraging CDMOs to scale pipelines quickly, reduce CAPEX, and accelerate market entry with regulatory-compliant infrastructure.

Read More »

March 2026


Digital Health Market Size, Trends & Forecast, By Technology (Telehealth, mHealth, AI in Healthcare, Digital Therapeutics, RPM), By Component (Software, Services, Hardware), By End Use (Hospitals, Homecare, Payers), By Region, 2025–2032

Rising chronic diseases, aging populations, and post-pandemic digital transformation have driven adoption of telemedicine, remote patient monitoring, and AI-based diagnostics.

Read More »

June 2025


mRNA Therapeutics Market Size, Share & Forecast, By Type (Prophylactic Vaccines, Therapeutic Vaccines, mRNA Cancer Immunotherapies), By Application (Infectious Diseases, Oncology, Genetic Disorders), By Delivery Method (Lipid Nanoparticles, Electroporation), By Region, 2025–2032

The success of mRNA COVID-19 vaccines has validated the platform’s scalability and adaptability. Investments in oncology, personalized vaccines, and rare genetic disorders are accelerating R&D and market growth for mRNA-based therapeutics.

Read More »

June 2025


Showing 21 to 30 of 31 Entries